Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice

Microbial Pathogenesis

Volumn 26, Issue 6, 1999, Pages 299-305

  Coynault, Colette ^a   Norel, Françoise ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Regulation; rpoS; Salmonella; Sigma factor; Vaccine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; LIVE VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STRAIN DIFFERENCE;

EID: 0033151563     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1999.0273     Document Type: Article

References (24)

1. s as a global regulator in the osmotic control of gene expression in Escherichia coli. Mol Microbiol 1996; 21: 887-93.
2. Ishihama A. Adaptation of gene expression in stationary phase bacteria. Current Opin Genet Devel 1997; 7: 582-8.
3. Fang FC, Libby SJ, Buchmeier NA, Loewen PC, Switala J, Harwood J, Guiney DG. The alternative sigma factor KatF (RpoS) regulates Salmonella virulence. Proc Natl Acad Sci USA 1992; 89: 11978-82.
4. Norel F, Robbe-Saule V, Popoff MY, Coynault C. The putative sigma factor KatF (RpoS) is required for the transcription of the Salmonella typhimurium virulence gene spvB in Escherichia coli. FEMS Microbiol Lett 1992; 99: 271-6.
5. Kowarz L, Coynault C, Robbe-Saule V, Norel F. The Salmonella typhimurium katF (rpoS) gene: Cloning, nucleotide sequence and regulation of spvR and spvRABCD virulence plasmid genes. J Bacterial 1994; 176: 6852-60.
6. Robbe-Saule V, COynault C, Norel F. The live oral typhoid vaccine Ty21a is a rpoS mutant and is susceptible to various environmental stresses. FEMS Microbiol Lett 1995; 126: 171-6.
7. s) regulon. Mol Microbiol 1996; 22: 149-60.
8. Nickerson CA, Curtiss R. Role of factor RpoS in initial stage of Salmonella typhimurium infection. Infect Immun 1997; 65: 1814-23.
9. Khan AQ, Zhao L, Hirose K, Miyake M, Li T, Hashimoto Y, Kawamura Y, Ezaki T. Salmonella typhi rpoS mutant is less cytotoxic than the parent strain but survives inside resting THP-1 macrophages. FEMS Microbiol Lett 1998; 161: 201-8.
10. Collins FM. Vaccines and cell-mediated immunity. Bac Rev 1974; 38: 371-402.
11. Everest P, Griffiths P, Dougan G. Live Salmonella vaccines as a route towards oral immunisation. Biologicals 1995; 23: 119-24.
12. Hoiseth SK, Stocker BAD. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291: 238-9.
13. Robbe-Saule V, Norel F. The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a. FEMS Microbiol Lett 1999; 170: 141-3.
14. Harrison JA, Villarreal-Ramos B, Maastroeni P, Demarco de Hormaeche R, Hormaeche C. Correlates of protection induced by live aro Salmonella typhimurium vaccines in the murine typhoid model. Immunology 1997; 90: 618-25.
15. Hormaeche CE, Mastroeni P, Harrison JA, Demarco de Hormaeche R, SVenson S, Stocker BAD. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live aroA Salmonella typhimurium and Salmonella enteritidis vaccines is sero- type (species)-dependent and only partially determined by the main LPS O antigen. Vaccine 1996; 14: 251-9.
16. Izhar M, DeSilva L, Joysey HS, Hormaeche CE. Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice. Infect Immun 1990; 58: 2258-61.
17. Hess J, Ladel C, Miko D, Kaufmann SHE. Salmonella typhimurium aroA infection in gene-targeted immunodeficient mice. J Immunol 1996; 156: 3321-6.
18. Sinha K, Mastroeni P, Harrison J, Demarco de Hormaeche R, Hormaeche CE. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect Immun 1997; 65: 1566-9.
19. Tackett CO, Hone DM, Curtiss III R, Kelly SM, Losonsky G, Guers L, Harris AM, Edelman R, Levine MM. Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect Immun 1992; 60: 536-41.
20. Tackett CO, Hone DM, Losonsky GA, Guers L, Edelman R, Levine MM. Clinical acceptability and immunogenicity of CVD908 Salmonella typhi vaccine strain. VacCine 1992; 10: 443-6.
21. Hone DM, Tackett CO, Harris AM, Kay B, Losonsky G, Levine MM. Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest 1992; 90: 412-20.
22. Schmieger H. Phage P22 mutants with increased or decreased transduction abilities. Mol Gen Genet 1972; 119: 75-8.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
24. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938; 27: 493-7.